Mechanical thrombectomy for large vessel occlusion between 6 and 24 h: outcome comparison of DEFUSE-3/DAWN eligible versus non-eligible patients.

Publication

Mechanical thrombectomy for large vessel occlusion between 6 and 24 h: outcome comparison of DEFUSE-3/DAWN eligible versus non-eligible patients.

Journal Paper/Review - Dec 14, 2022

Dittrich Tolga, Sporns Peter B, Kriemler Lilian, Rudin Salome, Nguyen Anh, Zietz Annaelle, Polymeris Alexandros A, Traenka Christopher, Thilemann Sebastian, Wagner Benjamin, Altersberger Valerian L, Piot Ines, Barinka Filip, Hänsel Martin, Gensicke Henrik, Engelter Stefan T, Lyrer Philippe A, Sutter Raoul, Nickel Christian H, Katan Mira, Peters Nils, Michels Lars, Kulcsar Zsolt, Karwacki Grzegorz M, Pileggi Marco, Cereda Carlo W, Wegener Susanne, Bonati Leo H, Fischer Urs, Psychogios Marios-Nikos, De Marchis Gian Marco

Citation

Dittrich T, Sporns P, Kriemler L, Rudin S, Nguyen A, Zietz A, Polymeris A, Traenka C, Thilemann S, Wagner B, Altersberger V, Piot I, Barinka F, Hänsel M, Gensicke H, Engelter S, Lyrer P, Sutter R, Nickel C, Katan M, Peters N, Michels L, Kulcsar Z, Karwacki G, Pileggi M, Cereda C, Wegener S, Bonati L, Fischer U, Psychogios M, De Marchis G. Mechanical thrombectomy for large vessel occlusion between 6 and 24 h: outcome comparison of DEFUSE-3/DAWN eligible versus non-eligible patients. Int J Stroke 2022; 18:697-703.

Type

Journal Paper/Review (English)

Journal

Int J Stroke 2022; 18

Publication Date

Dec 14, 2022

Issn Electronic

1747-4949

Pages

697-703

Brief description/objective

The DEFUSE-3 and DAWN trials showed that mechanical thrombectomy (MT) improves the outcome of selected patients with anterior circulation large vessel occlusions (LVO) up to 24 h after stroke onset. However, it is unknown whether only those patients fulfilling the trial inclusion criteria benefit, or whether benefit is seen in a broader range of patients presenting between 6 and 24 h.